Difference between revisions of "Team:CU Boulder/project/results"

Line 31: Line 31:
 
}
 
}
 
#graph {
 
#graph {
     height: 550px;
+
     height: 500px;
 
     width: 500px;
 
     width: 500px;
 
     background-image: url(https://static.igem.org/mediawiki/2015/9/9f/CU_Boulder_arabinose_graph.png);
 
     background-image: url(https://static.igem.org/mediawiki/2015/9/9f/CU_Boulder_arabinose_graph.png);
Line 38: Line 38:
 
     background-repeat: no-repeat;
 
     background-repeat: no-repeat;
 
     margin: 30px auto;
 
     margin: 30px auto;
 +
    margin-bottom: 5px;
 
border: 3px solid blue;
 
border: 3px solid blue;
 
}
 
}

Revision as of 23:08, 12 September 2015


<!DOCTYPE html> Team:CU_Boulder - 2015.igem.org

Results


Testing response of pBAD promoter with Arabinose

Because we are using pBad as our promoter to start the cascade of responses in our system, we needed to test the leakiness of the promoter. To do this, we put pBad on a 1C3 plasmid with Red Fluorescent Protein (RFP).

The promoter, pBad, turns on in the presence of arabinose and in doing so, allows RFP to be transcribed. Therefore, once arabinose is present, our cells will fluoresce red.

The amount that our cells fluoresce depends on the amount of arabinose. To further characterize this observation, we grew up overnights with varying concentrations of arabinose and measured their fluorescence.

Initially, we documented with pictures to illustrate the change in fluorescence and we observed a relatively smooth increase in brightness as the arabinose concentration increased.

Varied concentrations of arabinose from 0% to 0.2% by 0.04% increments (7/14/15)


Then we used flow cytometry to more accurately characterize the fluorescence:



As illustrated in the flow cytometry characterization, we do see some cells fluorescing even when no arabinose is present, therefore the pBad promoter is leaky.

Our device simply requires a human to monitor the cells and therefore since the human eye cannot pick up any red in the 0% arabinose, our promoter is sufficient for its intended purposes. However to further reduce the leakiness, we have attacked the issue from various angles such as putting the construct on a lower copy plasmid, therefore reducing the effects of leakiness even more.

Team:CU-Boulder - 2015.igem.org